FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ZNF587B-NEK9

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ZNF587B-NEK9
FusionPDB ID: 102469
FusionGDB2.0 ID: 102469
HgeneTgene
Gene symbol

ZNF587B

NEK9

Gene ID

100293516

91754

Gene namezinc finger protein 587BNIMA related kinase 9
Synonyms-APUG|LCCS10|NC|NERCC|NERCC1
Cytomap

19q13.43

14q24.3

Type of geneprotein-codingprotein-coding
Descriptionzinc finger protein 587Bserine/threonine-protein kinase Nek9NIMA (never in mitosis gene a)- related kinase 9nercc1 kinasenimA-related protein kinase 9
Modification date2020031320200320
UniProtAcc.

Q8TD19

Main function of 5'-partner protein: FUNCTION: Pleiotropic regulator of mitotic progression, participating in the control of spindle dynamics and chromosome separation. Phosphorylates different histones, myelin basic protein, beta-casein, and BICD2. Phosphorylates histone H3 on serine and threonine residues and beta-casein on serine residues. Important for G1/S transition and S phase progression. Phosphorylates NEK6 and NEK7 and stimulates their activity by releasing the autoinhibitory functions of Tyr-108 and Tyr-97 respectively. {ECO:0000269|PubMed:12840024, ECO:0000269|PubMed:14660563, ECO:0000269|PubMed:19941817}.
Ensembl transtripts involved in fusion geneENST idsENST00000316462, ENST00000442832, 
ENST00000594901, 
ENST00000555763, 
ENST00000238616, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score12 X 7 X 7=5884 X 7 X 3=84
# samples 147
** MAII scorelog2(14/588*10)=-2.0703893278914
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/84*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ZNF587B [Title/Abstract] AND NEK9 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ZNF587B [Title/Abstract] AND NEK9 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ZNF587B(58350517)-NEK9(75573405), # samples:1
Anticipated loss of major functional domain due to fusion event.ZNF587B-NEK9 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ZNF587B-NEK9 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ZNF587B-NEK9 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ZNF587B-NEK9 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:58350517/chr14:75573405)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ZNF587B (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NEK9 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000316462ZNF587Bchr1958350517+ENST00000238616NEK9chr1475573405-44003421251954609
ENST00000442832ZNF587Bchr1958350517+ENST00000238616NEK9chr1475573405-44553971142009631
ENST00000594901ZNF587Bchr1958350517+ENST00000238616NEK9chr1475573405-4437379961991631

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000316462ENST00000238616ZNF587Bchr1958350517+NEK9chr1475573405-0.0025755510.9974245
ENST00000442832ENST00000238616ZNF587Bchr1958350517+NEK9chr1475573405-0.002537080.99746287
ENST00000594901ENST00000238616ZNF587Bchr1958350517+NEK9chr1475573405-0.0026678680.9973321

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ZNF587B-NEK9

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ZNF587Bchr1958350517NEK9chr147557340534272DVTLENLALMSSLDEGQLYAFGSDYY
ZNF587Bchr1958350517NEK9chr147557340537994DVTLENLALMSSLDEGQLYAFGSDYY
ZNF587Bchr1958350517NEK9chr147557340539794DVTLENLALMSSLDEGQLYAFGSDYY

Top

Potential FusionNeoAntigen Information of ZNF587B-NEK9 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ZNF587B-NEK9_58350517_75573405.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:25SSLDEGQLY0.99760.75721019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B35:08SSLDEGQLY0.99260.66051019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-A02:21SLDEGQLYA0.99220.57951120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:17SSLDEGQLY0.98760.76991019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B35:01SSLDEGQLY0.96090.69171019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B58:01SSLDEGQLY0.9090.6381019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:03SSLDEGQLY0.78620.55641019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B58:02SSLDEGQLY0.7450.68031019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:17MSSLDEGQLY0.99360.7205919
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B13:01SLDEGQLYAF0.81010.73551121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B57:03SSLDEGQLYAF0.99950.85181021
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C05:09SLDEGQLYA0.99980.87031120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C08:15SLDEGQLYA0.9910.93971120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:05SSLDEGQLY0.98180.70291019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:31SSLDEGQLY0.95090.70951019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C15:04SSLDEGQLY0.78160.73811019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C03:14SSLDEGQLY0.16560.94571019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C12:04SSLDEGQLY0.07250.93861019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C06:03SSLDEGQLY0.06450.91971019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C12:12SSLDEGQLY0.02110.77041019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C04:10SLDEGQLYAF10.64411121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C05:09SLDEGQLYAF10.83321121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C04:07SLDEGQLYAF0.99990.68081121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C08:15SLDEGQLYAF0.99980.91361121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:05SLDEGQLYAF0.93720.81771121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:05LMSSLDEGQLY0.98550.6947819
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C05:01SLDEGQLYA0.99980.87031120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C04:03SLDEGQLYA0.99980.81771120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:39SSLDEGQLY0.99710.66431019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-A02:06SLDEGQLYA0.99220.57951120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C08:02SLDEGQLYA0.9910.93971120
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:20SSLDEGQLY0.98470.74341019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B35:11SSLDEGQLY0.98060.72161019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B57:04SSLDEGQLY0.97990.55281019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B35:28SSLDEGQLY0.97370.73511019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B35:20SSLDEGQLY0.96160.74181019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B35:77SSLDEGQLY0.96090.69171019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:135SSLDEGQLY0.93460.73381019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C03:02SSLDEGQLY0.8460.92191019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C15:09SSLDEGQLY0.78160.73811019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:12SSLDEGQLY0.76840.72371019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B48:02SSLDEGQLY0.70020.73741019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C16:04SSLDEGQLY0.29510.90771019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C12:02SSLDEGQLY0.25270.84771019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C16:02SSLDEGQLY0.18990.93851019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C16:01SSLDEGQLY0.09270.9041019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C02:02SSLDEGQLY0.00590.87491019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C02:10SSLDEGQLY0.00590.87491019
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C04:03SLDEGQLYAF10.731121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C05:01SLDEGQLYAF10.83321121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C04:01SLDEGQLYAF0.99990.68081121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C08:02SLDEGQLYAF0.99980.91361121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-C18:01SLDEGQLYAF0.99980.70541121
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B57:04MSSLDEGQLY0.99850.5899919
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B57:04SSLDEGQLYAF0.99990.5951021
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B57:02SSLDEGQLYAF0.99980.74841021
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:135LMSSLDEGQLY0.99960.6541819
ZNF587B-NEK9chr1958350517chr1475573405342HLA-B15:20LMSSLDEGQLY0.98490.7883819

Top

Potential FusionNeoAntigen Information of ZNF587B-NEK9 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of ZNF587B-NEK9

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4764LALMSSLDEGQLYAZNF587BNEK9chr1958350517chr1475573405342

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ZNF587B-NEK9

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4764LALMSSLDEGQLYA-7.15543-7.26883
HLA-B14:023BVN4764LALMSSLDEGQLYA-4.77435-5.80965
HLA-B52:013W394764LALMSSLDEGQLYA-6.80875-6.92215
HLA-B52:013W394764LALMSSLDEGQLYA-4.20386-5.23916
HLA-A11:014UQ24764LALMSSLDEGQLYA-7.5194-8.5547
HLA-A11:014UQ24764LALMSSLDEGQLYA-6.9601-7.0735
HLA-A24:025HGA4764LALMSSLDEGQLYA-7.52403-7.63743
HLA-A24:025HGA4764LALMSSLDEGQLYA-5.82433-6.85963
HLA-B27:056PYJ4764LALMSSLDEGQLYA-3.28285-4.31815
HLA-B44:053DX84764LALMSSLDEGQLYA-5.91172-6.94702
HLA-B44:053DX84764LALMSSLDEGQLYA-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of ZNF587B-NEK9

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ZNF587B-NEK9chr1958350517chr14755734051019SSLDEGQLYCCTCCCTGGATGAGGGTCAGCTCTATG
ZNF587B-NEK9chr1958350517chr14755734051021SSLDEGQLYAFCCTCCCTGGATGAGGGTCAGCTCTATGCCTTCG
ZNF587B-NEK9chr1958350517chr14755734051120SLDEGQLYACCCTGGATGAGGGTCAGCTCTATGCCT
ZNF587B-NEK9chr1958350517chr14755734051121SLDEGQLYAFCCCTGGATGAGGGTCAGCTCTATGCCTTCG
ZNF587B-NEK9chr1958350517chr1475573405819LMSSLDEGQLYTTATGTCCTCCCTGGATGAGGGTCAGCTCTATG
ZNF587B-NEK9chr1958350517chr1475573405919MSSLDEGQLYTGTCCTCCCTGGATGAGGGTCAGCTCTATG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of ZNF587B-NEK9

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAZNF587B-NEK9chr1958350517ENST00000316462chr1475573405ENST00000238616TCGA-BH-A18S

Top

Potential target of CAR-T therapy development for ZNF587B-NEK9

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ZNF587B-NEK9

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ZNF587B-NEK9

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource